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Summary.-The leucocyte migration and guinea-pig macrophage migration proce-
dures were used to assess cell mediated, tumour directed immune reactions in
patients with mammary carcinoma undergoing simple mastectomy with or without
post-operative irradiation. Forty-seven per cent of patients reacted to autologous
tumour antigens and40o% to allogeneic antigens when tested 7 days after operation;
23% reacted to autologous antigens at 2 months, 19% at 6 months and 34%0 at 1 year
after surgery. Reactions to benign tissue fractions were rare. Better discrimina-
tionbetweentest and control subjects was obtained when3000 g sediments rather than
nuclei-depleted homogenates (extracts) were used. Irradiation 3-7 weeks post-
operatively did not depress the in vitro response at 2 months and yielded a higher
rate of positive reactions at 6 months. Correlations of serial LMT responses with
certain clinical findings are discussed.
A NUMBER of procedures have been
Lused to demonstrate tumour directed,
cell mediated immunity (CMI) in patients
with mammary carcinoma. Delayed
lhypersensitivity reactions were observed
following intradermal challenge with mam-
mary tumour extracts by Hughes and
Lytton (1964), Stewart and Orizaga (1971)
and Alford, Hollinshead and Herberman
(1973), while the skin window technique
was used by Black and Leis (1970, 1971,
1973) to show that cellularhypersensitivity
reactions correlated well with the stage of
the disease and sinus histiocytosis in the
draining lymph nodes at the time of
mastectomy.
In vitro techniques uLsed to demonstrate
lymphocyte mediated reactions to mam-
mary tumour cells or cell fractions have
included lymphocytotoxicity (Hellstr6m
et al., 1971; Fossati et al., 1972); lympho-
cyte transformation (Fischer et al., 1.969)
and lymphocyte production of migration
inhibition factor (Andersen et al., 1970;
Wolberg, 1971; Segall et al., 1972; Cochran
et al., 1974). The method that has been
most widely studied and appears best
suited to the examination of CMI to
tumour antigens in breast cancer patients
is the leucocyte migration test (LMT) of
S0borg and Bendixen (1967); this method
has been used primarily in population
studies and the possibility of obtaining
information of value in determining prog-
nosis and in planning treatments of
patients has stimulated the present study
of serial responses following surgery for
mammarv carcinoma.
MATERIALS AND METHOl)S
Patients.-105 patients with Stage I or
Stage 11 mammary carcinoma form part of
an on-going therapeutic survey comparing
simple mastectomy with simple mastectomy
plus radical radiotherapy. Approximately
halfofthese patients were randomly allocated
regional radiotherapy, which was given
between the third and seventh post-operative
week. The remaining patients were closely
observed and irradiated only in the event of
local recurrence. At the time of operation,
biopsies were taken from the tumour draining
axillary lymph nodes and examined for
metastatic tumour deposits.B. M. JONES AND A. R. TURNBULL
Controls.-The control group consisted
of 19 healthy hospital workers, 12 hospital
in-patients with malignant diseases of sites
other than breast, 4 pregnant females and 9
patients with benign breast disease, each of
whom was tested against several tumours.
Tissue fractions.-Malignant and benign
breast tissues obtained at operation were
dissected clear of fat and necrotic tissue,
minced with scissors and disrupted by 10-20
strokes with the loose-fitting dounce-type
glass hand homogenizer (pestle clearance
0412 mm) followed by 5-10 strokes with the
tight-fitting homogenizer (pestle clearance
0 07 mm). Homogenates were centrifu c-d
at 1000 g to remove nuclei, cell debris L-id
unbroken cells and the supernatants (extracts
-Andersen et al., 1970) were also further
centrifuged to give a 3000 a sediment (Wolf,
1969). Fractions were adjusted to a protein
concentration of 2 mg/ml and dispensed into
aliquots of0-2 ml. They were stored at -20°C
until the day ofthe test, when dilutions were
made in tissue culture medium 199 containing
10% foetal calf serum, 13 mmol/l NaHCO3,
20 mmol/l HEPES buffer, 200 Ztg/ml L-gluta-
mine, 300 i.u./ml penicillin and 300 jig/ml
streptomycin, to 50, 100, 150 and 200 ug/ml.
In vitro tests.-Patients were tested
against autologous tumour fractions at 7
days, 2 months, 6 months and 1 year after
operation, and against allogeneic malignant
and, in some cases, benign tissue fractions at
7 days. Tests employing control leucocytes
were set up concurrently. 25 ml samples of
blood were taken into 20 u/ml preservative-
free heparin and leucocytes separated by
allowing erythrocytes to sediment through
Ficoll-Triosil columns for 60 min at room
temperature. Cells were washed 3 times in
medium 199, counted and suspended at
16 x 106/ml in the same medium.
The method used for leucocyte migration
was similar to that of Federlin et al. (1971),
except that 3 instead of 2 capillaries, each
containing 6 x 105 leuicocytes, were mounted
within each well of the Sterilin migration
chamber. After 18 h migration at 37°C,
migration areas were measured by projection
microscopy and planimetry and migration
indices (MI) for each dilution of antigen
calculated as follows:
MI Average migration area in antigen
Average migration area in medium
MI values below 0-80 (average control MI-
2 s.d.) were taken to indicate migration
inhibition. It was not possible to set up
migration tests against tumour fractions in
duplicate because of the need to conserve
material for follow-up tests, but duplicate
migrations in control medium were always
performed.
In a small number ofcases, parallel studies
were performed using a guinea-pig macro-
phage migration test (MMT) similar to that
employed by Rajapakse and Glynn (1970).
Guinea-pig macrophages were obtained as
peritoneal exudates 3 days after the intra-
peritoneal injection of 20 ml sterile liquid
paraffin, and were washed 3 times in medium
199. Lymphocytes from breast cancer
patients or control subjects were separated
from whole heparinized blood by centri-
fugation at 1000 g for 30 min on Ficoll-
Triosil columns and were similarly washed.
Capillaries were filled with either macro-
phages alone or macrophages mixed with
control or patients' lymphocytes in the ratio
10 :1. Migration into medium 199 supple-
mented with 15% pooled complement deacti-
vated guinea-pig serum and 500 jug/ml
L-glutamine, with or without 50-200 jig/ml
tumour extract or3000 gfraction, wasallowed
to proceed for 3 days at 37°C.
RESULTS
Leucocyte and guinea-pig macrophage
migrations were both highly reproducible,
with individual migration areas within 8%
of the mean for each migration well and
average migrations for duplicate cultures
in control medium without antigen invari-
ably within 5% of each other. The two
methods gave comparable results (Table
I); inhibition of leucocyte migration
occurred in 2/35 control tests and macro-
phage migration inhibition in 1/35; 32/35
(91%) control tests gave the same result
by the two methods. 15/35 (43%)
patients were positive by LMT and 8/35
(23%) by MMT to autologous tumour
extract or 3000y fraction; 7 of the
LMT-positive patients were negative by
MMT but agreement occurred in 28/35
(80%) tests (P < 0-01, Chi-squared with
Yates' correction).
Leucocyte migration results for
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TABLE I.-Summary of Leucocyte Migra-
tion (LMT) and Guinea-pig Macrophage
Migration (MMT) Results for 35 Breast
Cancer Patients tested against Autologous
Tumour Fractions, and for Control
Subjects tested against theSameFractions.
LMT gave More Positive Results than
MMT, but Overall Agreement .between
the Two Methods occurred in 60/70 (86%)
Tests (P < 0'01, C-hi-squared with Yates'
Correction)
LMT +ive MMT +ive Agreement
Controls a2/35 (6%) bl/35 (30%) 32/35 (91%)
Patients c15/35 (43%) d8/35 (23%) 28/35 (80%)
a These 2 patients -ive by MMT.
b This patient -ive by LMT.
c Includes 7 patients -ive by MMT.
d All +ive by LMT.
TABLE II.-Leucocytes from Control Sub-
jects orPatients withBenign orMalignant
Breast Disease were Tested against
Extracts and 3000 g Fractions Prepared
from Benign Breast Tissue. Positive
Reactions were Rare in All Cases
Leucocytes
Control
Benign
Malignant
+ive to
extract
0/10
0/5
0/10
+ive to
3000 g
fraction
1/10 (10%)
0/4
2/19 (11%)
+ive to
extract
and/or
3000 g
fraction
1/10 (10%)
0/5
2/19 (11%)
patients with benign or malignant breast
disease and for control healthy subjects
tested against benign tissue fractions are
shown in Table II. Inhibition was
observed in 1/10 controls and 2/19 breast
cancer patients, while 5 patients with
benign disease were negative.
Table III summarizes LMT results for
patients tested against autologous tumour
extract and 3000 g fraction at 7 days, 2
months, 6 months and 1 year after opera-
tion, and against allogeneic antigens at
7 days. Control tests were performed
on each occasion to examine the effect of
prolonged storage of tumour fractions on
control leucocyte migration. At 7 days
after operation, breast cancer patients
reacted to autologous extract in 31/105
24
TABLE III.-Breast Cancer Patients were
Tested by Leucocyte Migration against
Autologous Tumour Extract and 3000 g
Fraction 7 days, 2 months, 6 months and
1 year after Operation and against
Allogeneic Tumour Fractions at 7 days.
Tests employing Control Leucocytes were
set up Concurrently. The 3000 g Frac-
tions gave Better Discrimination between
Test and Control Subjects than the
Extracts at all Times after Operation.
There was a Significant Reduction in the
Proportion of Patients Positive to Auto-
logous Breast Tumour Fractions at 2 and
6 Months after Operation Compared with
the 7 day Results (P < 0*001, Chi-
squared test) and the Rate of Positive
Reactions at 1 year was Increased by
Comparison with the 6 month Results,
though this Increase did Not Attain
Statistical Significance
Leucocytes
Autologous Ca
breast 7 days
post-op
Allogeneic Ca
breast 7 days
post-op
7 day controls
Autologous Ca
breast 2
months post-
op
2 month
controls
Autologous Ca
breast 6
months post-
op
6 month
controls
Autologous Ca
breast 1 year
post-op
1 year
controls
+ive to
extract
31/105
(30%)d
12/64
(19%)C
5/104
(5%)
11/97
(11 %)b
3/97
(3 %)
7/75
(9 %)a
4/73
(5%)
9/50
(18%)
+ive to
3000 g
fraction
38/105
(36%)d
28/88
(32%)d
2/103
(2 %)
19/90
(21%)c
6/90
(7%)
10/70
(14Y%)c
1/69
(1%)
14/43
(33 c
1/47 2/38
(2%) (5%)
a Not significant (Chi-squared test).
b p < 0.05.
cp < 0*01.
d p < 0-001.
+ive to
extract
and/or
3000 g
fraction
49/105
(47%)d
35/88
(40%)d
6/104
(6%)
22/97
(23%)c
7/97
(7%)
14/75
(19%)C
4/73
(5%)
17/50
(34%)d
3/47
(6%)
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(30%) and allogeneic extract in 12/64
(19%) cases, values which were signifi-
cantly different (Chi-squared test) from
control leucocyte migrations (5/104, 5%).
Rather more patients reacted to auto-
logous (38/105, 36%) and allogeneic (28/88,
32%) 3000 g fraction, with only 2/103
(2%) such fractions giving control inhibi-
tion. In all, 49/105 (47%) breast cancer
patients reacted to autologous extract
and/or 3000 g fraction at 7 days, 35/88
(40%) to allogeneic antigens and 6/104
(6%) tumours gave extracts or 3000 g
fractions which inhibited control leucocyte
migrations.
Eleven of 97 (11%) patients re-tested
2 months after surgery responded to
autologous extract and 19/90 (21%) to
autologous 3000 q fraction, with 22/97
(23%) patients positive to at least one of
the antigens. This value was significantly
lower (P < 0 001, Chi-squared test) than
positives found at 7 days. At 6 months
after operation, 14/75 (19%) patients
responded, 7/75 (9%) toautologous extract
and 10/70 (14%) to autologous 3000 g
fraction; these values were not signifi-
cantly different from 2 month results.
At 1 year post-surgery, 17/50 (34%)
patients were positive, 9/50 (18%) to
autologous extract and 14/43 (33%) to
autologous 3000 g fraction, and although
there was no significant difference between
these and the 6 month results, a trend
towards an increased rate of positives at
1 year was apparent.
DISCUSSION
Horizontal studies of cellular immune
reactions have revealed an unexpected,
and at the present time unexplained,
fluctuation in the reactivity of breast
cancer patients' leucocytes towards auto-
logous breast tumour antigens over a
period of a year following the operation
of simple mastectomy. Of 57 patients
on whom studies have been completed,
16 (28%) remained negative throughout
the period of testing; 3 (5%) were con-
sistently positive; 15 (26%) were initially
positive but failed to react in later tests;
5 (8%) were negative in the 7 day and 2
month tests but were positive subse-
quently; 10 (18%) were positive at 7 days
and 12 months but negative in between;
and 8 (14%) were negative at 7 days and
12 months butpositive inbetween. In all,
47% of patients reacted at 7 days after
operation; 23% at 2 months, 19% at
6 months and 34% at 1 year. Reduced
reactivity in the 2 and 6 month tests could
not be explained by exposure to thera-
peutic irradiation, since 11/50 (22%)
irradiated and 11/47 (23%) non-irradiated
patients reacted at 2 months after opera-
tion, at a time when regional radiotherapy
had just been completed. Results at
6 months after operation suggested that
radiotherapy might in fact encourage
in vitro reactivity, since 11/35 (31%)
irradiated patients reacted, while only
3/40 (8%) untreated patients were positive
(P < 0 05, Chi-squared with Yates' cor-
rection). This was an unexpected finding
in view of previous reports of lympho-
penia (Meyer, 1970; McCredie, Inch and
Sutherland, 1972) and reduced PHA
induced blast transformation (Stjernsward
et al., 1972) following prophylactic irradia-
tion of the breast.
An attempt was made to correlate
serial LMT results with certain other
clinical findings, including the presence
or absence of metastatic deposits in the
tumour draining axillary lymph nodes
(LNM), skin test reactivity to 3 common
recall antigens (PPD, streptokinase-
streptodornase and Candida), lymphocyte
infiltration of the tumour, stimulation of
the axillary lymph nodes, and survival.
Although statistically significant differ-
ences between groups of patients were not
apparent, we observed trends towards
increased reactivity at 2 months after
operation in patients with LNM and
decreased reactivity at 1 year in these
patients and in the small number of
patients who have succumbed to their
disease. Patients anergic on skin test
and showing no lymphocytic involvement
at the site of the tumour or in axillary
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lymph nodes reacted less frequently at all
times.
In the 7 day tests, 47% of patients
reacted to autologous and 40% to allo-
geneic breast tumour antigens; 28/45
(62%) patients positive to autologous
antigens also reacted to allogeneic tumour
preparations, while only 7143 (16%)
patients negative to autologous antigens
cross-reacted with allogeneic tumours
(P < 0-001, Chi-squared with Yates' cor-
rection). This might indicate that nega-
tive in vitro results truly indicated a lack
of reactivity on the part of the patient
and were not due to variations in the
fractionation of tumours.
Seventy of 391 (18%) tests of breast
cancer patients' leucocytes against tumour
extracts gave positive results, while 109/
396 (28%) tests were positive using
3000 g fractions (P < 0 01, Chi-squared
test). Migration of leucocytes from
healthy volunteers, patients with tumours
of sites other than breast and patients
with benign breast disease were rarely
inhibited by either preparation, although
one pregnant control subject reacted to
2/4 tumours. Benign tissue fractions
did not inhibit the migration ofleucocytes
from patients with benign or malignant
breast disease, though it is possible that
these tissues were not susceptible to
antigen separation by the methods used
for tumours.
Results presented in this paper con-
firm the value of the LMT in demonstrat-
ing tumour directed CMI in mammary
carcinoma patients. Comparable results
were obtained in guinea-pig macrophage
and leucocyte migration tests, though the
latter appeared more sensitive and is
considered more suitable for use under
survey-type conditions because of its
simpler and less time-consuming metho-
dology. Studies described here are to be
continued and it is intended that the
patterns ofreactivity ofindividual patients
will be assessed inrelation to theirsurvival,
results which will be communicated in due
course.
We are grateful to Tenovus (Cardiff)
for financing this on-going project. All
patients studied were under the care of
Professor Sir James Fraser and Dr J.
Shepherd at the Royal South Hants
Hospital, and we would like to acknow-
ledge their continued support and interest.
We also wish to thank Professors Ralph
Wright and George Stevenson for helpful
advice and comments, and Mrs M. Evans
for her expert technical assistance.
REFERENCES
ALFORD, C., HOLLINSHEAD, A. C. & HERBERMAN,
R. B. (1973) Delayed Cutaneous Hypersensitivity
Reactions to Extracts of Malignant and Normal
Human Breast Cells. Ann. Sury., 178, 20.
ANDERSEN, V., BJERRUM, O., BENDIXEN, G.,
SCHI0DT, T. & DISSING, I. (1970) Effect of
Autologous Mammary Tumour Extracts on
Human Leukocyte Migration in vitro. Int. J.
Cancer, 5, 357.
BLACK, M. M. & LEIS, H. P. (1970) Human Breast
Carcinoma. III. Cellular Responses to Auto-
logous Breast Cancer: Skin Window Procedure.
N.Y. State J. Med., 70, 2583.
BLACK,M. M. & LEIS, H. P. (1971) Cellular Responses
to Autologous Breast Cancer Tissue. Correlation
with Stage and Lymphoreticuloendothelial Reacti-
vity. Cancer, N.Y., 28, 263.
BLACK, M. M. & LEIS, H. P. (1973) Cellular Responses
to Autologous Breast Cancer Tissue. Sequential
Observations. Cancer, N.Y., 32, 384.
COCHRAN, A. J., GRANT, R. M., SPILG, W. G.,
MACKIE, R. M., Ross, C. E., HOYLE, D. E. &
RUSSELL, J. M. (1974) Sensitization to Tumour-
associated Antigens in Human Breast Carcinoma.
Int. J. Cancer, 14, 19.
FEDERLIN, K., MAINI, R. N., RUSSELL, A. S. &
DUMONDE, D. C. (1971) A Micromethod for
Peripheral Leukocyte Migration in Tuberculin
Sensitivity. J. clin. Path., 24, 533.
FISCHER, P., GOLOB, E., HOLZNER, H. & KUNZE-
MUHL, E. (1969) Comparative Effects of Tumour
Extracts on Lymphocyte Transformation in
Peripheral Blood Cultures of Healthy Persons and
Patients with Breast Cancer. Z. Kreb8for8ch.,
72, 155.
FoSSATI, G., CANEVARI, S., DELLA PORTA, G.,
BALZARINI, G. P. & VERONESI, U. (1972) Cellular
Immunity to Human Breast Carcinoma. Int. J.
Cancer, 10, 391.
HELLSTR6M, I., HELLSTR6M, K. E., SJSGREN, H. 0.
& WARNER, G. A. (1971) Demonstration of Cell-
mediated Immunity to Human Neoplasms of
Various Histological Types. Int. J. Cancer, 7, 1.
HUGHES, L. E. & LYTTON, B. (1964) Antigenic
Properties ofHumanTumours: DelayedCutaneous
Hypersensitivity Reactions. Br. med. J., i, 209.
MCCREDIE, J. A., INCH, W. R. & SUTHERLAND, R. M.
(1972) Effect of Post-operative Radiotherapy on
Peripheral Blood Lymphocytes in Patients with
Carcinoma of the Breast. Cancer, N.Y., 29,
349.344 B. M. JONES AND A. R. TURNBULL
MHYER, K. K. (1970) Radiation-induced Lympho-
cyte-immune Deficiency. Arch8 Surg. 101, 114.
RAJAPAKSE, D. A. & GLYNN, L. E. (1970) Macro-
phage Migration Inhibition Test using Guinea-pig
Macrophages and Human Lymphocytes. Nature,
Lond., 226, 857.
SEGALL, A., WEILER, O., GENIN, J., LACOUR, J. &
LACouR, F. (1972) In vitro Study of Cellular
Immunity against Autochthonous Human Cancer.
Int. J. Cancer, 9, 417.
SOBOR, M. & BENDIXEN, G. (1967) HumanLympho-
cyte Migration as a Parameter ofHypersensitivity.
Acta med. 8cand., 181, 247.
STEWART, T. H. M. & ORIZAGA, M. (1971) The
Presence of Delayed Hypersensitivity Reactions
in Patients towards Cellular Extracts of their
Malignant Tumors. Cancer, N.Y., 28, 1472.
STJERNSWARD, J., JONDAL, M., VANKY, F., WIGZELL,
H. & SEALY, R. (1972) Lymphopenia and Changes
in Distribution of Human B and T Lymphocytes
in Peripheral Blood Induced by Irradiation for
Mammary Carcinoma. Lancet, i, 1352.
WOLBERG, W. H. (1971) Inhibition of Migration of
Human Autogenous and Allogeneic Leukocytes
by Extracts of Patients' Cancers. Cancer Re8.,
31, 798.
WOLF, A. (1969) The Activity of Cell-free Tumour
Fractions in Inducing, Immunity across a Weak
Histocompatibility Barrier. Tran8plantation, 7,
49.